Immunovia AB (publ) (LON:0G8X)
0.2000
-0.0090 (-4.31%)
At close: Feb 3, 2026
Immunovia AB Employees
Immunovia AB had 12 employees as of September 30, 2025. The number of employees increased by 3 or 33.33% compared to the same quarter last year.
Employees
12
Change
3
Growth
33.33%
Revenue / Employee
5.17K GBP
Profits / Employee
-825.80K GBP
Market Cap
9.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 12 | 3 | 33.33% |
| Jun 30, 2025 | 8 | -2 | -20.00% |
| Mar 31, 2025 | 9 | -2 | -18.18% |
| Dec 31, 2024 | 9 | -2 | -18.18% |
| Sep 30, 2024 | 9 | -16 | -64.00% |
| Jun 30, 2024 | 10 | -29 | -74.36% |
| Mar 31, 2024 | 11 | -40 | -78.43% |
| Dec 31, 2023 | 11 | -53 | -82.81% |
| Sep 30, 2023 | 25 | -39 | -60.94% |
| Jun 30, 2023 | 39 | -25 | -39.06% |
| Mar 31, 2023 | 51 | -18 | -26.09% |
| Dec 31, 2022 | 64 | -1 | -1.54% |
| Sep 30, 2022 | 64 | -4 | -5.88% |
| Jun 30, 2022 | 64 | -5 | -7.25% |
| Mar 31, 2022 | 69 | 0 | - |
| Dec 31, 2021 | 65 | -2 | -2.99% |
| Sep 30, 2021 | 68 | 1 | 1.49% |
| Jun 30, 2021 | 69 | 10 | 16.95% |
| Mar 31, 2021 | 69 | 11 | 18.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| CelLBxHealth | 119 |
| IXICO | 79 |
| genedrive | 43 |
| Oxford BioDynamics | 41 |
Immunovia AB News
- 2 months ago - Immunovia AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Immunovia AB (FRA:1YR) Q3 2025 Earnings Call Highlights: Transition to Commercial Stage with ... - GuruFocus
- 2 months ago - Q3 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 2 months ago - Immunovia AB (publ) (IMMVF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Q2 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 1 year ago - Immunovia AB (LTS:0G8X) Q4 2024 Earnings Call Highlights: Breakthroughs in Testing and ... - GuruFocus
- 1 year ago - Q4 2024 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 1 year ago - Immunovia reports Q4 results - Seeking Alpha